Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 9,018 | 4,475 | 7,990 | -8,121 | 15,562 |
| Cost of Goods | 259 | 234 | 213 | -3,035 | 197 |
| Gross Profit | 8,759 | 4,241 | 7,777 | -5,086 | 15,365 |
| Operating Expenses | 283,399 | 346,188 | 110,225 | 134,998 | -5,111,893 |
| Operating Income | -274,381 | -341,713 | -102,235 | -140,119 | 5,127,455 |
| Other Income | 39,868 | 117,330 | 82,595 | 121,929 | 26,090 |
| Pre-tax Income | -234,513 | -224,383 | -19,640 | -18,190 | 5,153,545 |
| Income Tax | -25,568 | 12,458 | 11,963 | -5,850 | 22,365 |
| Net Income Continuous | -208,945 | -236,841 | -31,603 | -12,340 | 5,131,180 |
| Net Income Discontinuous | 327,020 | -43,083 | 89,093 | -170,156 | -58,515 |
| Minority Interests | -51,306 | -49,740 | -37,807 | -31,381 | -23,519 |
| Net Income | $169,381 | $-230,184 | $95,297 | $-151,115 | $5,096,184 |
| EPS Basic Total Ops | 0.23 | -0.31 | 0.13 | -0.04 | 6.37 |
| EPS Basic Continuous Ops | -0.29 | -0.32 | -0.04 | 0.14 | 6.41 |
| EPS Basic Discontinuous Ops | 0.45 | -0.06 | 0.12 | -0.22 | -0.07 |
| EPS Diluted Total Ops | 0.23 | -0.31 | 0.12 | -0.02 | 6.03 |
| EPS Diluted Continuous Ops | -0.29 | -0.32 | -0.04 | 0.14 | 6.08 |
| EPS Diluted Discontinuous Ops | 0.45 | -0.06 | 0.11 | -0.20 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.37 | -0.24 | N/A | N/A |
| EBITDA(a) | $-271,460 | $-336,871 | $-97,352 | $-134,894 | $5,132,840 |